SPDYA and cancer: Loss of Spy1 decreases tumor onset and reduces the cancer stem cell population.<h4>Conclusions</h4>This data demonstrates the potential of Spy1 to expand mammary stem cell populations and contribute to the initiation and progression of aggressive, breast cancers with increased cancer stem cell populations.